Literature DB >> 18199488

IL-24 modulates IFN-gamma expression in patients with tuberculosis.

Bo Wu1, Chunhong Huang, Midori Kato-Maeda, Philip C Hopewell, Charles L Daley, Alan M Krensky, Carol Clayberger.   

Abstract

IL-24 is a newly described member of the IL-10 family. We previously demonstrated that PBMC from TB patients exhibited low levels of IL-24 and IFN-gamma compared to subjects with latent tuberculosis infection (LTBI). In order to investigate the role of IL-24 in IFN-gamma expression in TB patients, we stimulated PBMC from individuals with LTBI or TB patients with the Mtb-specific antigen, early secretory antigenic target-6 (ESAT-6) and measured cytokine expression using quantitative real-time PCR (qPCR). Exogenous IL-24 increased IFN-gamma expression in PBMC obtained from TB patients while neutralization of IL-24 reduced IFN-gamma expression in PBMC from subjects with LTBI. Exogenous IL-24 enhanced IFN-gamma expression by increasing expression of IL-12 family cytokines, including IL-12alpha, IL-12beta, IL-23alpha and IL-27, and by reducing FOXP3 expression in PBMC from TB patients. This is the first demonstration that IL-24 may play an important role in IFN-gamma expression following infection with Mtb.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18199488      PMCID: PMC2679252          DOI: 10.1016/j.imlet.2007.11.018

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  24 in total

Review 1.  Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy.

Authors:  M T Madireddi; Z Z Su; C S Young; N I Goldstein; P B Fisher
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Is the development of a new tuberculosis vaccine possible?

Authors:  S H Kaufmann
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

Review 3.  IL-9 and its receptor: from signal transduction to tumorigenesis.

Authors:  Laurent Knoops; Jean-Christophe Renauld
Journal:  Growth Factors       Date:  2004-12       Impact factor: 2.511

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells.

Authors:  Nancy J Poindexter; Eugene T Walch; Sunil Chada; Elizabeth A Grimm
Journal:  J Leukoc Biol       Date:  2005-07-06       Impact factor: 4.962

6.  Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR.

Authors:  T Mark Doherty; Abebech Demissie; Dick Menzies; Peter Andersen; Graham Rook; Alimuddin Zumla
Journal:  J Immunol Methods       Date:  2005-03       Impact factor: 2.303

Review 7.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.

Authors:  Mai Wang; Zhongjia Tan; Rong Zhang; Sergei V Kotenko; Peng Liang
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

9.  IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis.

Authors:  Bo Wu; Chunhong Huang; Midori Kato-Maeda; Philip C Hopewell; Charles L Daley; Alan M Krensky; Carol Clayberger
Journal:  Clin Immunol       Date:  2007-11-26       Impact factor: 3.969

10.  IL-24 is expressed by rat and human macrophages.

Authors:  Holger Garn; Ansgar Schmidt; Veronika Grau; Sabine Stumpf; Andreas Kaufmann; Mike Becker; Diethard Gemsa; Anette Siese
Journal:  Immunobiology       Date:  2002-07       Impact factor: 3.144

View more
  6 in total

1.  Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Nathella Pavan Kumar; Kadar Moideen; Dhanaraj Baskaran; Syed Hissar; Basavegowdanadoddi M Shrinivasa; Rathinam Sridhar; Subash Babu
Journal:  Cytokine       Date:  2018-06-02       Impact factor: 3.861

Review 2.  Mechanism of Action and Applications of Interleukin 24 in Immunotherapy.

Authors:  Leah Persaud; Dayenny De Jesus; Oliver Brannigan; Maria Richiez-Paredes; Jeannette Huaman; Giselle Alvarado; Linda Riker; Gissete Mendez; Jordan Dejoie; Moira Sauane
Journal:  Int J Mol Sci       Date:  2016-06-02       Impact factor: 5.923

Review 3.  Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.

Authors:  Luni Emdad; Praveen Bhoopathi; Sarmistha Talukdar; Anjan K Pradhan; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Paul B Fisher
Journal:  Semin Cancer Biol       Date:  2019-07-26       Impact factor: 15.707

4.  Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence.

Authors:  Pauline Bade; Fabrizio Simonetti; Stephanie Sans; Patricia Laboudie; Khadija Kissane; Nicolas Chappat; Sophie Lagrange; Florence Apparailly; Christine Roubert; Isabelle Duroux-Richard
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

Review 5.  Interleukin-10 Family and Tuberculosis: An Old Story Renewed.

Authors:  Abualgasim Elgaili Abdalla; Nzungize Lambert; Xiangke Duan; Jianping Xie
Journal:  Int J Biol Sci       Date:  2016-04-27       Impact factor: 6.580

Review 6.  Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?

Authors:  Hyun-Eui Park; Wonsik Lee; Min-Kyoung Shin; Sung Jae Shin
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.